Status
Conditions
About
Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Full description
Cross-sectional and longitudinal analysis of cellular immune responses in the context of disease outcome.
Cross-sectional and longitudinal analysis of the microbiome in the context of disease outcome.
Analysis of renal function with respect of different HIPEC regimens
Identification of clinical surrogate parameters for outcome.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
250 participants in 2 patient groups
Loading...
Central trial contact
Jens M Werner, MD; Monika Diehl-Bein
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal